Association of screen time variables with sleep quality of respondents (n = 259). by Isha Aryal (22582068)

Subjects:

Frequency and percentage on screen time questionnaire of respondents (n = 259). by Isha Aryal (22582068)

Subjects:

PLE inhibits IMQ-induced inflammatory in mice, and the contents of TNF-α (A) and IL-17A (B). by Xiaoqiang Huang (1457860)

Results of weighted arcsine-transformed linear regression of the age-and sex-standardised epilepsy prevalence (y) and age- and sex-standardised anti-Ov16 seroprevalence (x<sub>1</s... by Luís-Jorge Amaral (16406704)

Subjects:

Mean plasma concentration-time profiles of paeoniflorin and paeonol comparing low and high repeated doses of MC in DNBS-induced colitis rats. by Jin-Hwa Kim (101817)

δ¹⁵N in <i>Fucus spiralis</i> vs. <i>F. vesiculosus.</i> by Antonio Bode (1473376)

Subjects:

Changes associated with kidney fibrosis and effects of MN705 treatment on TGF- by Wencheng Jin (13136262)

Aβ and vGlut2 staining of 6-, 9-, and 12-month dLGN sections show significant plaque load and accelerated loss of retinal ganglion cell axon terminals in the 5xFAD mice. by Shaylah McCool (20818280)

Changes related to kidney staining in UUO mouse model. by Wencheng Jin (13136262)

Changes associated with kidney fibrosis in TGF- by Wencheng Jin (13136262)

The screening process of MN705. by Wencheng Jin (13136262)

Validation of MN705 treatment effects in human proximal tubular epithelial cells during TGF- by Wencheng Jin (13136262)

Effect of MN705 treatment on TGF- by Wencheng Jin (13136262)

Supplementary Tables 1–8. by Juliane F. Tampé (19976538)

Subjects:

Renal (urea and creatinine) (a, b) and Liver function (ALT and AST) (c, d) test in serums of different experimental groups and body weight changes (e) on day 10. by Omid Mehrpour (9385929)

The characteristics and clinical features of 12 patients. by Masashi Okawa (8951294)

Subjects:

Effect of the VEGF-A–bevacizumab complex removal using immunoprecipitation on the concentrations of VEGF-A121, VEGF-A165, and VEGF-A. by Masashi Okawa (8951294)

Subjects:

Equation of the equilibrium dissociation constant of the antigen-antibody reaction. by Masashi Okawa (8951294)

Subjects:

The original data for the figures. by Masashi Okawa (8951294)

Subjects:

Blood concentrations of VEGF-A121, VEGF-A165, and VEGF-A pre- and post-bevacizumab administration. by Masashi Okawa (8951294)

Subjects: